Alpha Tau Medical (DRTS) traded higher on Wednesday after Piper Sandler upgraded the stock to Overweight from Neutral, citing a catalyst-rich period for the oncology therapeutics company over the next 12 months.

Piper analyst Allison Bratzel noted that Israel-based Alpha